Related references
Note: Only part of the references are listed.Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer
Caryn S. Ross-Innes et al.
GENES & DEVELOPMENT (2010)
A CTCF-independent role for cohesin in tissue-specific transcription
Dominic Schmidt et al.
GENOME RESEARCH (2010)
CCCTC-binding Factor Acts Upstream of FOXA1 and Demarcates the Genomic Response to Estrogen
Yu Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Genome-Wide Dynamics of Chromatin Binding of Estrogen Receptors alpha and beta : Mutual Restriction and Competitive Site Selection
Tze Howe Charn et al.
MOLECULAR ENDOCRINOLOGY (2010)
ChIP-Seq of ERα and RNA polymerase II defines genes differentially responding to ligands
Willem-Jan Welboren et al.
EMBO JOURNAL (2009)
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers
Jerrome Eeckhoute et al.
GENOME RESEARCH (2009)
An oestrogen-receptor-α-bound human chromatin interactome
Melissa J. Fullwood et al.
NATURE (2009)
ChIP-seq: Using high-throughput sequencing to discover protein-DNA interactions
Dominic Schmidt et al.
METHODS (2009)
CCCTC-Binding Factor Confines the Distal Action of Estrogen Receptor
Chang S. Chan et al.
CANCER RESEARCH (2008)
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
Mathieu Lupien et al.
CELL (2008)
Nuclear receptor location analyses in mammalian genomes:: From gene regulation to regulatory networks
Genevieve Deblois et al.
MOLECULAR ENDOCRINOLOGY (2008)
Unique ERα Cistromes Control Cell Type-Specific Gene Regulation
Susan A. Krum et al.
MOLECULAR ENDOCRINOLOGY (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
FOXA1 expression in breast cancer - Correlation with luminal subtype A and survival
Sunil Badve et al.
CLINICAL CANCER RESEARCH (2007)
Whole-genome cartography of estrogen receptor α binding sites
Chin-Yo Lin et al.
PLOS GENETICS (2007)
FAIRE ((F)under-barormaldehyde-(A)under-barssisted (I)under-barsolation of (R)under-baregulatory (E)under-barlements) isolates active regulatory elements from human chromatin
Paul G. Giresi et al.
GENOME RESEARCH (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Genome-wide analysis of estrogen receptor binding sites
Jason S. Carroll et al.
NATURE GENETICS (2006)
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer
Jerome Eeckhoute et al.
GENES & DEVELOPMENT (2006)
CTCF mediates long-range chromatin looping and local histone modification in the β-globin locus
Erik Splinter et al.
GENES & DEVELOPMENT (2006)
A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Masashi Narita et al.
CELL (2006)
Location analysis of estrogen receptor α target promoters reveals that FOXA1 defines a domain of the estrogen response
J Laganière et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll et al.
CELL (2005)
Estrogen receptor α and β heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells
DG Monroe et al.
MOLECULAR ENDOCRINOLOGY (2005)
Selective estrogen receptor modulators:: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells
J Frasor et al.
CANCER RESEARCH (2004)
Relevance of breast cancer cell lines as models for breast tumours: an update
M Lacroix et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ
DG Monroe et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Enhanced estrogen receptor (ER) α, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation
LA Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells
JM Knowlden et al.
ENDOCRINOLOGY (2003)
Tamoxifen: A most unlikely pioneering medicine
VC Jordan
NATURE REVIEWS DRUG DISCOVERY (2003)
Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4
LA Cirillo et al.
MOLECULAR CELL (2002)
Endocrine-responsive breast cancer and strategies for combating resistance
S Ali et al.
NATURE REVIEWS CANCER (2002)
A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence
JS Carroll et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
YF Shang et al.
CELL (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
